EcoDrugPlus

Tubulin Beta 2b Class Iib

Ensembl ID : ENSCHYG00000001657
Gene Symbol: TUBB2B
1 Cross references
223 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSCHYG00000001415
Gene Symbol: TUBB3
1 Cross references
154 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSCHYG00000016548
Gene Symbol: TUBB4A
1 Cross references
89 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSCHYG00000016588
Gene Symbol: TUBB4B
1 Cross references
164 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSCHYG00000019004
Gene Symbol: TUBB6
1 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSCHYG00000000908
Gene Symbol: TUBB
1 Cross references
114 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSCHYG00000011475
Gene Symbol: TP53
1 Cross references
254 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSCHYG00000000943
Gene Symbol: TYR
1 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSCHYG00000002406
Gene Symbol: TH
1 Cross references
188 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSCHYG00000001767
Gene Symbol: TYK2
1 Cross references
197 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSCHYG00000025705
Gene Symbol: TIE1
1 Cross references
205 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSCHYG00000020531
Gene Symbol: UTS2R
1 Cross references
92 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).